Clinical Trials Directory

Trials / Completed

CompletedNCT04720222

Detectability of the Bladder With an Early Prototype of the Bladder Sensor

An Explorative, Monocentric, Feasibility Study to Evaluate the Detectability of the Bladder in Healthy Subjects by Ultrasound Monitoring With the Early TENA Bladder Sensor Prototype

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
91 (actual)
Sponsor
Essity Hygiene and Health AB · Industry
Sex
All
Age
35 Years – 74 Years
Healthy volunteers
Accepted

Summary

This is an explorative, monocentric, feasibility study to evaluate the detectability of the bladder in healthy subjects by ultrasound monitoring with the early prototype of a future bladder sensor, which is intended for use for an individual suffering from urinary incontinence.

Detailed description

The purpose of this clinical investigation with healthy subjects (defined as subjects without urological problems or lower urinary tract symptoms, assured by pre-defined inclusion and exclusion criteria) is to collect raw measurement data of the urinary bladder region of volunteers with the TENA-PROTO1, in multiple postural positions to evaluate the detectability of the bladder in the intended users and to determine the position criteria for the (future) ultrasound sensor on the lower abdomen. Secondarily, this clinical investigation aims to collect data on the adhesive and supportive belt used to fix the transducer assembly to the lower abdomen by the subject. Furthermore, safety of the subjects will be continously documented such as adverse events (AE) and device deficiencies (DD); AEs, Adverse Device Events (ADE), Severe Adverse Events (SAE), Severe Adverse Device effects (SADE), Unanticipated Serious Adverse Device Effects (USADE) and DDs.

Conditions

Interventions

TypeNameDescription
DEVICETENA-PROTO1Each volunteer will test the TENA-PROTO1 according to a standardized protocol in multiple postural positions to evaluate the detectability of the bladder by help of the investigational device

Timeline

Start date
2021-04-29
Primary completion
2021-10-19
Completion
2021-10-19
First posted
2021-01-22
Last updated
2021-11-24

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04720222. Inclusion in this directory is not an endorsement.